Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients
Clinical trial NCT00622869 · COMPLETED
Trial details
- NCT number
- NCT00622869
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2012-04-01
- Enrollment
- 719
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.